Meet Pittsburgh’s newest Nasdaq company, Coeptis Therapeutics

Coeptis is a cell therapy company, targeting the treatment of multiple myeloma, chronic lymphocytic leukemia and other CD38-type cancers by developing cell and gene therapies.